Post Intensive Care Accelerometery to Study and Support Recovery Outcomes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Edinburgh

About this trial

The primary purpose of this study is to find out whether a wrist-worn activity monitor can help healthcare professionals understand how people recover after they leave the intensive care unit (ICU), where they were cared for when they were most unwell. By tracking recovery at home, the device may help identify problems early so that the right support can be provided. The study involves adults who are discharged from the ICU in three hospitals in Edinburgh.

The main questions it aims to answer are:

* Can movement data from a wearable device give useful information about how people feel and function after they return home following ICU and then hospital discharge? * Do changes in activity levels relate to changes in symptoms like pain, anxiety or behavioural measures like daily functioning, sleep and cognition? There is no comparison group in this study.

Participants will:

* Wear a wrist-worn activity monitor * Answer a short set of health-related questionnaires

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18 years or older

Mechanical ventilation for more than 3 days

Total ICU length of stay greater than 7 days

Classified as "High Risk" using a validated High-Risk Tool*

Disqualifiers

Primary neurological diagnosis as the reason for ICU admission

Identified by the clinical team as being on the palliative care pathway

Physical activity primarily limited by the acute injury (e.g., major trauma or limb amputation)

Unable to mobilise independently prior to the index hospitalisation requiring ICU admission due to a long-term condition and/or disability

Trial population

Adults discharged from an intensive care unit and hospital who are at high risk of post-ICU syndrome and hospital readmission.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Feasibility of wearable data collection

The proportion of enrolled post-ICU patients achieving successful data collection. Successful data collection is defined as: * 16 hours of wear time within a 24-hour period and * 5 valid days per week for ≥ 3 of the 4 weeks during the two-month monitoring period.

Time frame
2 months after hospital discharge

Secondary outcomes

1

Telephone Questionnaire Completion Rate

The proportion of included post-ICU patients who successfully complete the battery of follow-up assessments, including the EQ-5D-5L, PSQI, T-MoCA, and PROMIS PF-10a questionnaires at the following time-frames: Baseline (Day 0 ± 5), 2 weeks (Day 14 ± 3), 1 month (Day 28 ± 3), and 2 months (Day 56 ± 3) post-hospital discharge.

Time frame
2 months after hospital discharge
2

Unplanned hospital readmission rate

The proportion of participants experiencing at least one unplanned hospital readmission following the index discharge.

Time frame
2 months after hospital discharge.
3

All-cause mortality

The proportion of participants who die from any cause following index hospital discharge.

Time frame
2 months after hospital discharge.
4

Health-Related Quality of Life (HRQoL)

Assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. This includes five domain scores (Mobility, Self-care, Usual activities, Pain/Discomfort, Anxiety/Depression) ranging from 1 (no problems) to 5 (extreme problems), and the EQ Visual Analogue Scale (EQ-VAS) ranging from 0 (worst imaginable health) to 100 (best imaginable health).

Time frame
Baseline (Day 0 ± 5), 2 weeks (Day 14 ± 3), 1 month (Day 28 ± 3), and 2 months (Day 56 ± 3) post-hospital discharge.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.